Prevalence and Clinical Profile of Myocardial Crypts in Hypertrophic Cardiomyopathy

Background— In hypertrophic cardiomyopathy (HCM), cardiovascular MR can detect morphological abnormalities of the left ventricle (LV) not visualized with echocardiography. Although myocardial crypts (ie, narrow, blood-filled invaginations within the LV wall) have been recognized in HCM, all clinical implications of these structural abnormalities within the broad clinical HCM spectrum are not completely resolved. Therefore, we sought to characterize the prevalence and diagnostic significance of myocardial crypts in HCM patients. Methods and Results— Cine and late gadolinium enhancement cardiovascular MR and 2-dimensional echocardiography were obtained in 292 consecutive patients with HCM including 31 genotype-positive/phenotype-negative family members without LV hypertrophy (28 ± 16 years; 51% male) and 261 patients with LV hypertrophy (46 ± 18 years; 60% male). Ninety-eight subjects without cardiovascular disease were controls. Myocardial crypts (1–6/patient) were identified only by cardiovascular MR in 19 of 31 genotype-positive/phenotype-negative patients (61%) compared with only 10 of 261 (4%) patients with HCM with LV hypertrophy (P<0.001) and were absent in control subjects. Twelve-lead electrocardiograms were normal in 10 (53%) of the genotype-positive/phenotype-negative patients with crypts. Crypts were confined to the basal LV, most commonly in the ventricular septum (n=21) or posterior LV free wall (n=4), and associated with normal LV contractility and absence of late gadolinium enhancement in all but one patient. Conclusions— LV myocardial crypts represent a distinctive morphological expression of HCM, occurring with different frequency in HCM patients with or without LV hypertrophy. Crypts are a novel cardiovascular MR imaging marker, which may identify individual HCM family members who should also be considered for diagnostic genetic testing. These data support an expanded role for cardiovascular MR in early evaluation of HCM families.

[1]  E. Nagel,et al.  Letter by Puntmann et al regarding article, "Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy". , 2012, Circulation. Cardiovascular imaging.

[2]  D. Bluemke,et al.  Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis , 2012, Journal of Cardiovascular Magnetic Resonance.

[3]  A. Wilde,et al.  Clinical assessment of the development of hypertrophic cardiomyopathy by cardiovascular magnetic resonance imaging , 2013 .

[4]  D. Bluemke,et al.  Trabeculated (non-compacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis , 2012, Journal of Cardiovascular Magnetic Resonance.

[5]  Edward W Hsu,et al.  Quantitative comparison of myocardial fiber structure between mice, rabbit, and sheep using diffusion tensor cardiovascular magnetic resonance , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[6]  P. Core Hypertrophic cardiomyopathy:quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging , 2011 .

[7]  D. Peters,et al.  Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. , 2011, Radiology.

[8]  S. Neubauer,et al.  Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia. , 2010, Journal of the American College of Cardiology.

[9]  S. Colan,et al.  Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. , 2010, The New England journal of medicine.

[10]  Barry J Maron,et al.  Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. , 2010, The American journal of cardiology.

[11]  R. Fattori,et al.  Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[12]  B. Maron,et al.  Ventricular septal crypt in hypertrophic cardiomyopathy. , 2010, European Heart Journal.

[13]  D. Pennell,et al.  Cardiovascular Magnetic Resonance , 2019, Cardiac CT, PET & MR.

[14]  W. Manning,et al.  Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.

[15]  W. Shou,et al.  Analysis of Ventricular Hypertrabeculation and Noncompaction Using Genetically Engineered Mouse Models , 2009, Pediatric Cardiology.

[16]  Ze-Zhou Song Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. , 2008, International journal of cardiology.

[17]  D. Jassal,et al.  Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[18]  W. Manning,et al.  Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[19]  D. Pennell,et al.  Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. , 2007, Journal of the American College of Cardiology.

[20]  A. van Rossum,et al.  Images in cardiovascular medicine. Prominent crypt formation in the inferoseptum of a hypertrophic cardiomyopathy mutation carrier mimics noncompaction cardiomyopathy. , 2007, Circulation.

[21]  Michael Jerosch-Herold,et al.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.

[22]  B. Maron,et al.  Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. , 2005, The American journal of cardiology.

[23]  D. Pennell,et al.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.

[24]  Claudia Stöllberger,et al.  Left ventricular hypertrabeculation/noncompaction. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[25]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[26]  S. Solomon,et al.  Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy , 2002, Circulation.

[27]  M. Quiñones,et al.  Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy , 2001, Circulation.

[28]  W. Roberts,et al.  Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. , 1992, The American journal of cardiology.

[29]  M. Silver,et al.  An improved method for detecting and quantifying cardiac muscle disarray in hypertrophic cardiomyopathy. , 1989, American heart journal.

[30]  B. Maron,et al.  Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood. , 1989, The American journal of cardiology.

[31]  D TEARE,et al.  ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS , 1958, British heart journal.